KUALA LUMPUR, Sept 29 (Bernama) -- Conagen has announced the commercialisation of its 99 per cent high-purity salidroside made by bioconversion technology, an active ingredient from the herbal plant Rhodiola rosea (golden root). Its strong antioxidant properties as an adaptogen are associated with reducing inflammation, protecting against oxidative stress in cells, and providing relief from depression, fatigue, and stress. Salidroside has also been used to alleviate high altitude sickness. Unlike other salidroside products currently on the market, Conagen’s salidroside is non-GMO. Conagen leveraged its industry-leading bioconversion technology to produce clean, sustainable salidroside, identical to the compound naturally found in the Rhodiola rosea plant --- the same technology used to produce non-GMO Rebaudioside M, other steviol glycosides, and bitter blockers for sugar reduction solutions which are available from their pipeline partner, Sweegen. Conagen’s 99 per cent high-purity salidroside, made by bioconversion, is ideal for non-GMO supplement solutions to formulate products with a sustainable and natural consumer appeal. It is readily soluble in water and is very formulable in food and beverage applications. “We’re reimagining the way in which rare ingredients are sourced to make them safer and higher-quality for use in health-promoting products,” said Casey Lippmeier, Ph.D., senior vice president of innovation at Conagen in a statement. “Our bioconversion technology enables us to deliver non-GMO products. Through this technology, we’re unlocking salidroside’s great potential as a powerful active health ingredient and as a tool for food and beverage producers to adopt a more natural way to preserve food and beverages.” Food and beverage producers benefit from Conagen’s salidroside as it also possesses antimicrobial properties, making it useful as a natural preservative solution for brands seeking alternatives to artificial preservatives. Salidroside expands Conagen’s portfolio of natural preservatives, such as Taxifolin BC-DHQ® and Rosavel™ rosmarinic acid, currently available from another pipeline partner, Blue California. Conagen accelerated salidroside production by leveraging one of its proprietary molecular platforms, which have also been used to produce the clean antioxidants hydroxytyrosol and p-coumaric acid. Salidroside is a glucoside of tyrosol. Conagen’s antimicrobial and antioxidant compounds, hydroxytyrosol and p-coumaric acid are also now available through Blue California. For more information, visit www.conagen.com. -- BERNAMA
0 Comments
Leave a Reply. |
Archives
April 2023
|